Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Nexavar, Herceptin could gain from cancer meeting
Fierce Pharma
Mon, 12/14/09 - 06:13 pm
Tags:
Nexavar, Herceptin, Genentech, breast cancer
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab
PR-Canada
Sun, 12/13/09 - 12:13 pm
Tags:
Roche, Genentech, Biogen Idec, ocrelizumab
Genentech sheds pact as pipeline review claims another deal
Fierce Biotech
Fri, 12/11/09 - 10:30 am
Tags:
pipelines, Genentech, Roche, Seattle Genetics, partnerships
More from Genentech's McCracken on the Future of Pharmaceutical Sales
BNET Pharma
Tue, 12/8/09 - 11:13 am
Tags:
pharmaceutical sales, Genentech, pharma industry
Genentech insists it hasn't lost its R&D mojo
Fierce Biotech
Mon, 11/30/09 - 11:08 am
Tags:
R&D, Genentech, Roche
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia
Yahoo/AP
Thu, 11/19/09 - 07:52 am
Tags:
Genentech, Roche, Biogen Idec, FDA, Rituxan, leukemia
Roche applies for Avastin advanced breast cancer use
Reuters
Tue, 11/17/09 - 10:45 am
Tags:
Avastin, Roche, breast cancer, Genentech
What Genentech and Roche Got From Congress for $15M
BNET Pharma
Sun, 11/15/09 - 06:17 pm
Tags:
Roche, congress, Genentech, healthcare reform
No Product Revenues, Plenty of Risk: Buy Exelixis?
CNBC
Mon, 11/9/09 - 09:58 am
Tags:
Exelixis, GSK, Bristol-Myers Squibb, Sanofi, Roche, Genentech
Medicare gives eye docs their way on Avastin
Fierce Pharma
Wed, 10/28/09 - 02:32 pm
Tags:
Avastin, Medicare, Lucentis, macular degeneration, Genentech
Brain Disease Found in 3rd Patient on Roche’s Rituxan
Bloomberg
Mon, 10/26/09 - 09:40 am
Tags:
Roche, Genentech, arthritis, Rituxan
Genentech brand to replace Roche in U.S.
Fierce Pharma
Mon, 10/19/09 - 06:41 pm
Tags:
Genentech, Roche
Genentech and Biogen Idec Receive a Complete Response from FDA for Earlier Use of Rituxan for Rheumatoid Arthritis
Businesswire
Mon, 10/19/09 - 07:45 am
Tags:
Rituxan, rheumatoid arthritis, Roche, Genentech, FDA
Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission
Reuters
Sun, 10/18/09 - 10:57 am
Tags:
Actemra, tocilizumab, rheumatoid arthritis, Genentech
Senator probes Medicare shift to Lucentis
Fierce Pharma
Wed, 10/14/09 - 10:49 am
Tags:
Medicare, Lucentis, Avastin, Genentech
Roche To Give Genentech Employees More Options
Pharmalot
Tue, 10/13/09 - 10:22 am
Tags:
Roche, Genentech, M&A
The inside scoop on Roche's integration of Genentech
Fierce Pharma
Thu, 10/8/09 - 08:34 am
Tags:
Roche, Genentech, restructuring, M&A
Lucentis improves sight after 7 days in 2 studies
Reuters
Mon, 10/5/09 - 10:48 am
Tags:
Lucentis, Genentech, RVO, retinal vein occlusion, Roche
Rituxan tests positive in Phase III trial
Fierce Pharma
Thu, 09/17/09 - 11:11 am
Tags:
Rituxan, Genentech, lymphoma
Roche taps new pharma head after Genentech buy
Reuters
Tue, 09/8/09 - 07:41 am
Tags:
Roche, Genentech, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.